PhoreMost Limited has appointed Gabriel Fox as Consulting Chief Medical Officer to lead the clinical development of its new cancer drug, PMC-001. This appointment comes as the company progresses towards first-in-human clinical trials.
Who to call at PhoreMost, and when
A new leader at PhoreMost brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day PhoreMost raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at PhoreMost, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
PhoreMost
Location
Cambridge, England, United Kingdom
About
PhoreMost is a biopharmaceutical company specializing in the development of next-generation drug targets through its innovative SITESEEKER platform. The company focuses on degrader programs, particularly in oncology and inflammatory diseases. With recent funding, it aims to advance its pipeline of novel degrader assets toward preclinical development. PhoreMost is committed to revolutionizing medicine through targeted protein degradation.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PhoreMost changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CambridgeBiotechnologyTherapeuticsPharmaceuticalBiopharma